Global Critical Care Diagnostics Market Size, Share, Opportunities, And Trends By Application (Haematology, Cardiac and lipid testing, Coagulation Testing, Microbial and Infectious Disease Testing, Others), By End Users (Hospitals and Clinics, Research Institutes and Labs) And Geography - Forecasts From 2023 To 2028

The critical care diagnostics market is expected to reach $20.603 billion by 2024 from $17.238 billion in 2018 growing at a CAGR of 3.02%. Critical care diagnostics is performed for critically ill or injured patients or terminally ill patients dealing with life-threatening conditions requiring sophisticated invasive/non-invasive monitoring devices. It deals with the specialized care and diagnosis of life-threatening diseases in patients. These tests enable physicians to rapidly and accurately diagnose the disease and react immediately for proper treatment without any delay. Examples of critical care diagnostics include cancer biomarker tests, cardiac markers diagnostics, drug abuse, pathogens screening, cholesterol screening, etc. The market is estimated to show robust growth during the given forecast period. The rise in the market may be attributed to the rising prevalence of chronic diseases such as cardiac diseases and cancer. Also, the rising adoption of critical care diagnostics by physicians for the quick and accurate diagnosis of life-threatening diseases will further augment the market growth during the forecast period. However, the high cost of such equipment and the lack of skilled professionals might hamper the market growth during the given time frame.

The Critical care diagnostics Market – Forecasts from 2019 to 2024 is an exhaustive study that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by application, end users, and geography.

The critical care diagnostics market has been segmented based on application, end users, and geography. By application, the market has been segmented as hematology, cardiac and lipid testing, coagulation testing, microbial and infectious disease testing, and others. By end users, the market has been segmented as diagnostic centers, research laboratories, home care settings, and others

 Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, the Middle East and Africa (MEA), and the Asia Pacific regions. The report also analyzes 16 countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities that each of these countries presents for the manufacturers.

Major players in the critical care diagnostics market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the critical care diagnostics market.

Segmentation

The critical care diagnostics market has been segmented by application, end users, and geography.

• By Application

• • Haematology
  • Cardiac and lipid testing
  • Coagulation testing
  • Microbial and infectious disease testing
  • Others

 

• By End Users

• • Diagnostic Centers
  • Research Laboratories
  • Home Care Settings
  • Others

 

• By Geography

• • North America

• • • USA
    • Canada
    • Mexico

 

• • South America

• • • Brazil
    • Argentina
    • Others

 

• • Europe

• • • Germany
    • France
    • United Kingdom
    • Italy
    • Others

 

• • Middle East and Africa

• • • Saudi Arabia
    • Israel
    • Others

 

• • Asia Pacific

• • • China
    • Japan
    • South Korea
    • India
    • Others

1. Introduction

1.1. Market Definition

1.2. Market Segmentation

2. Research Methodology

2.1. Research Data

2.2. Assumptions

3. Executive Summary

3.1. Research Highlights

4. Market Dynamics

4.1. Market Drivers

4.2. Market Restraints

4.3. Porters Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. Critical care diagnostics Market Analysis, by Application

5.1. Introduction

5.2. Haematology

5.3. Cardiac and lipid testing

5.4. Coagulation testing

5.5. Microbial and infectious disease testing

5.6. Others

6. Critical care diagnostics Market Analysis, by End Users

6.1. Introduction

6.2. Diagnostic Centers

6.3. Research Laboratories

6.4. Home Care Settings

6.5. Others

7. Critical care diagnostics Market Analysis, by Geography

7.1. Introduction

7.2. North America

7.2.1. North America Critical care diagnostics Market, By Application, 2018 to 2024

7.2.2. North America Critical care diagnostics Market, By End Users, 2018 to 2024

7.2.3. By Country

7.2.3.1. United States

7.2.3.1.1. By Application

7.2.3.1.2. By End Users

7.2.3.2. Canada

7.2.3.2.1. By Application

7.2.3.2.2. By End Users

7.2.3.3. Mexico

7.2.3.3.1. By Application

7.2.3.3.2. By End Users

7.3. South America

7.3.1. South America Critical care diagnostics Market, By Application, 2018 to 2024

7.3.2. South America Critical care diagnostics Market, By End Users, 2018 to 2024

7.3.3. By Country

7.3.3.1. Brazil

7.3.3.1.1. By Application

7.3.3.1.2. By End Users

7.3.3.2. Argentina

7.3.3.2.1. By Application

7.3.3.2.2. By End Users

7.3.3.3. Others

7.4. Europe

7.4.1. Europe Critical care diagnostics Market, By Application, 2018 to 2024

7.4.2. Europe Critical care diagnostics Market, By End Users, 2018 to 2024

7.4.3. By Country

7.4.3.1. Germany

7.4.3.1.1. By Application

7.4.3.1.2. By End Users

7.4.3.2. France

7.4.3.2.1. By Application

7.4.3.2.2. By End Users

7.4.3.3. United Kingdom

7.4.3.3.1. By Application

7.4.3.3.2. By End Users

7.4.3.4. Italy

7.4.3.4.1. By Application

7.4.3.4.2. By End Users

7.4.3.5. Others

7.5. Middle East and Africa

7.5.1. Middle East and Africa Critical care diagnostics Market, By Application, 2018 to 2024

7.5.2. Middle East and Africa Critical care diagnostics Market, By End Users, 2018 to 2024

7.5.3. By Country

7.5.3.1. Saudi Arabia

7.5.3.1.1. By Application

7.5.3.1.2. By End Users

7.5.3.2. Israel

7.5.3.2.1. By Application

7.5.3.2.2. By End Users

7.5.3.3. Others

7.6. Asia Pacific

7.6.1. Asia Pacific Critical care diagnostics Market, By Application, 2018 to 2024

7.6.2. Asia Pacific Critical care diagnostics Market, By End Users, 2018 to 2024

7.6.3. By Country

7.6.3.1. China

7.6.3.1.1. By Application

7.6.3.1.2. By End Users

7.6.3.2. Japan

7.6.3.2.1. By Application

7.6.3.2.2. By End Users

7.6.3.3. South Korea

7.6.3.3.1. By Application

7.6.3.3.2. By End Users

7.6.3.4. India

7.6.3.4.1. By Application

7.6.3.4.2. By End Users

7.6.3.5. Others

8. Competitive Environment and Analysis

8.1. Major Players and Strategy Analysis

8.2. Emerging Players and Market Lucrativeness

8.3. Mergers, Acquisitions, Agreements, and Collaborations

8.4. Vendor Competitiveness Matrix

9. Company Profiles

9.1. Abbott

9.2. bioMérieux SA

9.3. Danaher

9.4. Werfen Australia

9.5. Radiometer Medical ApS

9.6. Roche Diagnostics

9.7. Trivitron Healthcare

9.8. Siemens Healthcare GmbH

10. Appendix

Abbott

bioMérieux SA

Danaher

Werfen Australia

Radiometer Medical ApS

Roche Diagnostics

Trivitron Healthcare

Siemens Healthcare GmbH